The supplier and publisher of this document assume no liability for misuse, abuse, or unauthorized application of the information or material provided
Novo Nordisk estimates that only 2% of obesity cases are being treated by weight-loss drugs, Pot said
In recent years, glucagon-like peptide-1 receptor agonists (GLP-1RAs) have gained attention not only for their role in glycemic control in T2DM but also for their potential in weight management
Enzyme Engineering and Optimization The mid-2010s saw significant advancements in molecular biology, which led to better enzyme selection and the engineering of more heat-stable ketose 3-epimerases
The answer (for at least maximizing efficacy with limited toxicity) can be using specialized drug delivery systems (287289), such as nanopolymers, lipid-based nanocarriers, cyclodextrins and gene delivery